Previous Article | Next Article 
Infection and Immunity, January 2006, p. 394-398, Vol. 74, No. 1
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.1.394-398.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Immunological Correlates for Protection against Intranasal Challenge of Bacillus anthracis Spores Conferred by a Protective Antigen-Based Vaccine in Rabbits
Shay Weiss,1
David Kobiler,1
Haim Levy,1
Hadar Marcus,2
Avi Pass,2
Nili Rothschild,1 and
Zeev Altboum1*
Departments of Infectious Diseases,1
Biotechnology, Israel Institute for Biological Research, Ness-Ziona, Israel2
Received 11 August 2005/
Returned for modification 20 September 2005/
Accepted 2 October 2005
Correlates between immunological parameters and protection against Bacillus anthracis infection in animals vaccinated with protective antigen (PA)-based vaccines could provide surrogate markers to evaluate the putative protective efficiency of immunization in humans. In previous studies we demonstrated that neutralizing antibody levels serve as correlates for protection in guinea pigs (S. Reuveny et al., Infect. Immun. 69:2888-2893, 2001; H. Marcus et al., Infect. Immun. 72:3471-3477, 2004). In this study we evaluated similar correlates for protection by active and passive immunization of New Zealand White rabbits. Full immunization and partial immunization were achieved by single and multiple injections of standard and diluted doses of a PA-based vaccine. Passive immunization was carried out by injection of immune sera from rabbits vaccinated with PA-based vaccine prior to challenge with B. anthracis spores. Immunized rabbits were challenged by intranasal spore instillation with one of two virulent strains (strains Vollum and ATCC 6605). The immune competence was estimated by measuring the level of total anti-PA antibodies, the neutralizing antibody titers, and the conferred protective immunity. The results indicate that total anti-PA antibody titers greater than 1 x 105 conferred protection, whereas lower titers (between 104 and 105) provided partial protection but failed to predict protection. Neutralizing antibody titers between 500 and 800 provided partial protection, while titers higher than 1,000 conferred protection. In conclusion, this study emphasizes that regardless of the immunization regimen or the time of challenge, neutralizing antibody titers are better predictors of protection than total anti-PA titers.
* Corresponding author. Mailing address: P.O. Box 19, Ness-Ziona, Israel, 74100. Phone: 972-8-9381414. Fax: 972-8-9381639. E-mail:
altboum{at}iibr.gov.il.
Editor: D. L. Burns
Infection and Immunity, January 2006, p. 394-398, Vol. 74, No. 1
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.1.394-398.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wu, W., Mehta, H., Chakrabarty, K., Booth, J. L., Duggan, E. S., Patel, K. B., Ballard, J. D., Coggeshall, K. M., Metcalf, J. P.
(2009). Resistance of Human Alveolar Macrophages to Bacillus anthracis Lethal Toxin. J. Immunol.
183: 5799-5806
[Abstract]
[Full Text]
-
Osorio, M., Wu, Y., Singh, S., Merkel, T. J., Bhattacharyya, S., Blake, M. S., Kopecko, D. J.
(2009). Anthrax Protective Antigen Delivered by Salmonella enterica Serovar Typhi Ty21a Protects Mice from a Lethal Anthrax Spore Challenge. Infect. Immun.
77: 1475-1482
[Abstract]
[Full Text]
-
Tross, D., Klinman, D. M.
(2008). Effect of CpG Oligonucleotides on Vaccine-Induced B Cell Memory. J. Immunol.
181: 5785-5790
[Abstract]
[Full Text]
-
Omland, K. S., Brys, A., Lansky, D., Clement, K., Lynn, F., and the Participating Laboratories,
(2008). Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple Species. CVI
15: 946-953
[Abstract]
[Full Text]
-
Harvill, E. T., Osorio, M., Loving, C. L., Lee, G. M., Kelly, V. K., Merkel, T. J.
(2008). Anamnestic Protective Immunity to Bacillus anthracis Is Antibody Mediated but Independent of Complement and Fc Receptors. Infect. Immun.
76: 2177-2182
[Abstract]
[Full Text]
-
Peterson, J. W., Comer, J. E., Baze, W. B., Noffsinger, D. M., Wenglikowski, A., Walberg, K. G., Hardcastle, J., Pawlik, J., Bush, K., Taormina, J., Moen, S., Thomas, J., Chatuev, B. M., Sower, L., Chopra, A. K., Stanberry, L. R., Sawada, R., Scholz, W. W., Sircar, J.
(2007). Human Monoclonal Antibody AVP-21D9 to Protective Antigen Reduces Dissemination of the Bacillus anthracis Ames Strain from the Lungs in a Rabbit Model. Infect. Immun.
75: 3414-3424
[Abstract]
[Full Text]
-
Vitale, L., Blanset, D., Lowy, I., O'Neill, T., Goldstein, J., Little, S. F., Andrews, G. P., Dorough, G., Taylor, R. K., Keler, T.
(2006). Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.. Infect. Immun.
74: 5840-5847
[Abstract]
[Full Text]
-
Kobiler, D., Weiss, S., Levy, H., Fisher, M., Mechaly, A., Pass, A., Altboum, Z.
(2006). Protective antigen as a correlative marker for anthrax in animal models.. Infect. Immun.
74: 5871-5876
[Abstract]
[Full Text]
-
Gat, O., Grosfeld, H., Ariel, N., Inbar, I., Zaide, G., Broder, Y., Zvi, A., Chitlaru, T., Altboum, Z., Stein, D., Cohen, S., Shafferman, A.
(2006). Search for Bacillus anthracis Potential Vaccine Candidates by a Functional Genomic-Serologic Screen. Infect. Immun.
74: 3987-4001
[Abstract]
[Full Text]
-
Chitlaru, T., Gat, O., Gozlan, Y., Ariel, N., Shafferman, A.
(2006). Differential Proteomic Analysis of the Bacillus anthracis Secretome: Distinct Plasmid and Chromosome CO2-Dependent Cross Talk Mechanisms Modulate Extracellular Proteolytic Activities.. J. Bacteriol.
188: 3551-3571
[Abstract]
[Full Text]